BBNX
HealthcareBeta Bionics, Inc.
$10.39+0.28 (+2.77%)
Prev Close
$10.11
Open
$10.20
High
$10.62
Low
$10.20
Volume
547.9K
Market Cap
$468.8M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Beta Bionics, Inc. (BBNX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 37 insider sales totaling $4.03M. The most recent insider transaction was by Hopman Mark (officer: Chief Commercial Officer), who sold $4.1K worth of shares on Mar 5, 2026. Beta Bionics, Inc. operates in the Healthcare sector, within the Medical - Equipment & Services industry, with a market cap of $468.8M.
Buys (12M)
0
$0.00
Sells (12M)
37
$4.03M
Net Activity
Net Seller
$4.03M
Active Insiders
7
last 12 mo
BBNX Price Chart
BBNX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026↗ | Hopman Mark | officer: Chief Commercial Officer | Sell | 353 | $11.57 | $4.1K | 139,133 |
| Mar 3, 2026↗ | Feider Stephen | officer: Chief Financial Officer | Sell | 2,856 | $12.36 | $35.3K | 172,729 |
| Mar 3, 2026↗ | Hopman Mark | officer: Chief Commercial Officer | Sell | 1,668 | $12.36 | $20.6K | 139,486 |
| Mar 3, 2026↗ | Mensinger Mike | officer: Chief Product Officer | Sell | 2,128 | $12.36 | $26.3K | 188,793 |
| Mar 3, 2026↗ | Russell Steven Jon | officer: Chief Medical Officer | Sell | 2,052 | $12.36 | $25.4K | 179,096 |
| Mar 3, 2026↗ | Saint Sean | director, officer: President & CEO | Sell | 6,768 | $12.36 | $83.7K | 437,809 |
| Jan 7, 2026↗ | Mensinger Mike | officer: Chief Product Officer | Sell | 2,200 | $30.10 | $66.2K | 80,752 |
| Jan 6, 2026↗ | Mensinger Mike | Chief Product Officer | Sell | 2,200 | $30.10 | $66.2K | 0 |
| Jan 5, 2026↗ | Feider Stephen | officer: Chief Financial Officer | Sell | 20,000 | $29.53 | $590.7K | 42,614 |
| Jan 5, 2026↗ | Mensinger Mike | officer: Chief Product Officer | Sell | 7,800 | $29.61 | $230.9K | 83,552 |
| Jan 2, 2026↗ | Feider Stephen | Chief Financial Officer | Sell | 20,000 | $29.53 | $590.7K | 0 |
| Jan 2, 2026↗ | Mensinger Mike | Chief Product Officer | Sell | 7,800 | $29.61 | $230.9K | 0 |
| Dec 2, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 1,427 | $29.34 | $41.9K | 0 |
| Dec 2, 2025↗ | Mensinger Mike | Chief Product Officer | Sell | 1,063 | $29.34 | $31.2K | 0 |
| Dec 2, 2025↗ | Saint Sean | President & CEO | Sell | 3,278 | $29.34 | $96.2K | 0 |
| Dec 1, 2025↗ | Lezack Adam | Director | Sell | 1,406 | $29.55 | $41.5K | 0 |
| Dec 1, 2025↗ | Palasis Maria | Director | Sell | 1,406 | $29.55 | $41.6K | 0 |
| Oct 31, 2025↗ | Lezack Adam | Director | Sell | 1,406 | $26.87 | $37.8K | 0 |
| Oct 31, 2025↗ | Palasis Maria | Director | Sell | 1,406 | $26.91 | $37.8K | 0 |
| Oct 3, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 4,982 | $21.69 | $108.1K | 0 |
| Oct 1, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 15,018 | $20.76 | $311.8K | 0 |
| Sep 8, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 9,900 | $21.13 | $209.2K | 0 |
| Sep 5, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 100 | $21.00 | $2.1K | 0 |
| Sep 4, 2025↗ | Hopman Mark | Chief Commercial Officer | Sell | 18,229 | $20.34 | $370.8K | 0 |
| Sep 2, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 1,462 | $18.86 | $27.6K | 0 |
| Sep 2, 2025↗ | Hopman Mark | Chief Commercial Officer | Sell | 848 | $18.86 | $16.0K | 0 |
| Sep 2, 2025↗ | Mensinger Mike | Chief Product Officer | Sell | 1,089 | $18.86 | $20.5K | 0 |
| Sep 2, 2025↗ | Russell Steven Jon | Chief Medical Officer | Sell | 1,015 | $18.86 | $19.1K | 0 |
| Sep 2, 2025↗ | Saint Sean | President & CEO | Sell | 3,359 | $18.86 | $63.4K | 0 |
| Aug 22, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 4,413 | $17.01 | $75.1K | 0 |
| Aug 19, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 5,587 | $17.03 | $95.2K | 0 |
| Aug 19, 2025↗ | Hopman Mark | Chief Commercial Officer | Sell | 16,158 | $16.61 | $268.4K | 0 |
| Jun 2, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 1,497 | $17.89 | $26.8K | 0 |
| Jun 2, 2025↗ | Hopman Mark | Chief Commercial Officer | Sell | 868 | $17.89 | $15.5K | 0 |
| Jun 2, 2025↗ | Mensinger Mike | Chief Product Officer | Sell | 1,115 | $17.89 | $19.9K | 0 |
| Jun 2, 2025↗ | Russell Steven Jon | Chief Medical Officer | Sell | 1,039 | $17.89 | $18.6K | 0 |
| Jun 2, 2025↗ | Saint Sean | President & CEO | Sell | 3,439 | $17.89 | $61.5K | 0 |
| Jan 31, 2025↗ | Mensinger Mike | Chief Product Officer | Buy | 33,350 | $17.00 | $567.0K | 0 |
| Jan 31, 2025↗ | Mensinger Mike | Chief Product Officer | Sell | 10,588 | $0.04 | $432.50 | 0 |
BBNX Insider Buying Activity
The following table shows recent insider purchases of Beta Bionics, Inc. (BBNX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 31, 2025↗ | Mensinger Mike | Chief Product Officer | Buy | 33,350 | $17.00 | $567.0K | 0 |
BBNX Insider Selling Activity
The following table shows recent insider sales of Beta Bionics, Inc. (BBNX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026↗ | Hopman Mark | officer: Chief Commercial Officer | Sell | 353 | $11.57 | $4.1K | 139,133 |
| Mar 3, 2026↗ | Feider Stephen | officer: Chief Financial Officer | Sell | 2,856 | $12.36 | $35.3K | 172,729 |
| Mar 3, 2026↗ | Hopman Mark | officer: Chief Commercial Officer | Sell | 1,668 | $12.36 | $20.6K | 139,486 |
| Mar 3, 2026↗ | Mensinger Mike | officer: Chief Product Officer | Sell | 2,128 | $12.36 | $26.3K | 188,793 |
| Mar 3, 2026↗ | Russell Steven Jon | officer: Chief Medical Officer | Sell | 2,052 | $12.36 | $25.4K | 179,096 |
| Mar 3, 2026↗ | Saint Sean | director, officer: President & CEO | Sell | 6,768 | $12.36 | $83.7K | 437,809 |
| Jan 7, 2026↗ | Mensinger Mike | officer: Chief Product Officer | Sell | 2,200 | $30.10 | $66.2K | 80,752 |
| Jan 6, 2026↗ | Mensinger Mike | Chief Product Officer | Sell | 2,200 | $30.10 | $66.2K | 0 |
| Jan 5, 2026↗ | Feider Stephen | officer: Chief Financial Officer | Sell | 20,000 | $29.53 | $590.7K | 42,614 |
| Jan 5, 2026↗ | Mensinger Mike | officer: Chief Product Officer | Sell | 7,800 | $29.61 | $230.9K | 83,552 |
| Jan 2, 2026↗ | Feider Stephen | Chief Financial Officer | Sell | 20,000 | $29.53 | $590.7K | 0 |
| Jan 2, 2026↗ | Mensinger Mike | Chief Product Officer | Sell | 7,800 | $29.61 | $230.9K | 0 |
| Dec 2, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 1,427 | $29.34 | $41.9K | 0 |
| Dec 2, 2025↗ | Mensinger Mike | Chief Product Officer | Sell | 1,063 | $29.34 | $31.2K | 0 |
| Dec 2, 2025↗ | Saint Sean | President & CEO | Sell | 3,278 | $29.34 | $96.2K | 0 |
| Dec 1, 2025↗ | Lezack Adam | Director | Sell | 1,406 | $29.55 | $41.5K | 0 |
| Dec 1, 2025↗ | Palasis Maria | Director | Sell | 1,406 | $29.55 | $41.6K | 0 |
| Oct 31, 2025↗ | Lezack Adam | Director | Sell | 1,406 | $26.87 | $37.8K | 0 |
| Oct 31, 2025↗ | Palasis Maria | Director | Sell | 1,406 | $26.91 | $37.8K | 0 |
| Oct 3, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 4,982 | $21.69 | $108.1K | 0 |
| Oct 1, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 15,018 | $20.76 | $311.8K | 0 |
| Sep 8, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 9,900 | $21.13 | $209.2K | 0 |
| Sep 5, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 100 | $21.00 | $2.1K | 0 |
| Sep 4, 2025↗ | Hopman Mark | Chief Commercial Officer | Sell | 18,229 | $20.34 | $370.8K | 0 |
| Sep 2, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 1,462 | $18.86 | $27.6K | 0 |
| Sep 2, 2025↗ | Hopman Mark | Chief Commercial Officer | Sell | 848 | $18.86 | $16.0K | 0 |
| Sep 2, 2025↗ | Mensinger Mike | Chief Product Officer | Sell | 1,089 | $18.86 | $20.5K | 0 |
| Sep 2, 2025↗ | Russell Steven Jon | Chief Medical Officer | Sell | 1,015 | $18.86 | $19.1K | 0 |
| Sep 2, 2025↗ | Saint Sean | President & CEO | Sell | 3,359 | $18.86 | $63.4K | 0 |
| Aug 22, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 4,413 | $17.01 | $75.1K | 0 |
| Aug 19, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 5,587 | $17.03 | $95.2K | 0 |
| Aug 19, 2025↗ | Hopman Mark | Chief Commercial Officer | Sell | 16,158 | $16.61 | $268.4K | 0 |
| Jun 2, 2025↗ | Feider Stephen | Chief Financial Officer | Sell | 1,497 | $17.89 | $26.8K | 0 |
| Jun 2, 2025↗ | Hopman Mark | Chief Commercial Officer | Sell | 868 | $17.89 | $15.5K | 0 |
| Jun 2, 2025↗ | Mensinger Mike | Chief Product Officer | Sell | 1,115 | $17.89 | $19.9K | 0 |
| Jun 2, 2025↗ | Russell Steven Jon | Chief Medical Officer | Sell | 1,039 | $17.89 | $18.6K | 0 |
| Jun 2, 2025↗ | Saint Sean | President & CEO | Sell | 3,439 | $17.89 | $61.5K | 0 |
| Jan 31, 2025↗ | Mensinger Mike | Chief Product Officer | Sell | 10,588 | $0.04 | $432.50 | 0 |
BBNX Insiders
Similar Stocks to BBNX
LLY
Eli Lilly and Company
$984.11+0.70%
$921.90B
JNJ
Johnson & Johnson
$241.86-0.07%
$583.29B
ABBV
AbbVie Inc.
$220.81-2.02%
$398.49B
MRK
Merck & Co., Inc.
$115.92+0.00%
$286.57B
UNH
UnitedHealth Group Incorporated
$281.12+1.48%
$251.47B
AMGN
Amgen Inc.
$366.74-0.29%
$198.26B
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
GILD
Gilead Sciences, Inc.
$144.25-0.66%
$180.27B